Pharma | Business Post

FDI up 15 per cent last year, led by pharma and IT sectors

Pfizer facility in Dublin and Eli Lilly factory in Limerick account for €2.4 billion, while Intel plans to invest €12 billion to expand operations here

Irish economy technically in recession as GDP contracts again

GDP fell by 4.6 per cent in the first three months of this year – the second consecutive quarter during which it dropped

Big Pharma companies urge Irish government to oppose new EU law to increase competition

Global bosses of Pfizer, AstraZeneca, Janssen and more told Leo Varadkar that the rules ‘will seriously put at risk Europe’s standing in the global race to attract investments to develop new treatments for patients, jobs and growth’

Sterling Pharma to invest €30m in Ringaskiddy site and treble production

Company plans to boost headcount to manage increased production capacity

Hvivo hails ‘transformative’ year after trebling earnings

Contracted order-book increased by 65 per cent to £76 million

AstraZeneca exec calls on UK, EU to do more to attract investment after pharma giant opted for Ireland

Pam Cheng also said there were problems in Europe with the speed of regulatory authorisations

Pharma giant Gilead Sciences announces €45m expansion of Cork base

Construction for the new facility is to start in April 2023 and is expected to take 19 months

Uniphar reports earnings of €98 million for 2022

Irish-listed healthcare group is active in Europe, North America, Asia-Pacific and the Middle East and North Africa

AstraZeneca CEO says pharma giant chose Ireland over UK because of tax rates and green energy

Pascal Soriot said drugmaker initially wanted to make a $360 million investment in the UK but that the country’s tax rate was “discouraging”

Hvivo to make return to shareholders from strong 2022 results

Pharmaceutical services company expects full-year revenues of £50.6 million for 2022, a 30 per cent increase year-on-year

Cathal Friel’s Hvivo expects record revenue of £50.6 million in 2022

The Dublin-listed company formerly known as Open Orphan has issued a trading update

Pfizer warned government that low drug budget will delay access to new medicines

The pharma giant, which employs around 4,000 people here, said Ireland was 24th out of 35 countries for the availability of new medicines

Horizon in separate sale talks with Sanofi, Johnson & Johnson and Amgen

Dublin-based global pharma company disclosed on Wednesday it was in talks about a potential sale of the company

Horizon gets green light for €1bn biopharma factory

Global pharma firm Horizon Therapeutics has received planning permission to develop Waterford biopharmaceutical plant

The Big Interview

‘For our HQ, I was always going to have to be talked out of Ireland’ – Leo Sheridan, Advanced Clinical

Leo Sheridan’s Advanced Clinical, which carries out research trials on new drugs, is expanding into Ireland and the Chicago entrepreneur plans to bring the company’s new international headquarters to Dublin

Global supply chains still ‘unpredictable’, but improving

Sheri Lewis of Avantor, a US chemicals and materials company which has just opened a specialised distribution centre in Dublin, sees lead times shortening and costs coming down, ‘but it’s still quite fragile’

Biogen to urgently appeal court judgment allowing generic MS drug

High Court decision would pave the way for the sale of a generic multiple sclerosis drug and save the HSE over €8 million, but pharma giant claims the firm behind the drug is infringing on its patent

DPS €295m deal will be ‘game changer’ for engineering services sector

Dutch company Arcadis’s purchase of the Dublin-based firm will give it a new global reach, say industry sources

Ipsen to open upgraded €52m Dublin manufacturing facility

French pharmaceutical giant is increasing production of cancer and rare disease medicines at Blanchardstown site, and plans further growth here

The Big Interview

‘If we can give a bit of hope, that is really important’ – Eibhlín Mulroe, Cancer Trials Ireland

When the chief executive of Cancer Trials Ireland was aged just 18, two of her schoolmates were shot dead by the loyalist Ulster Volunteer Force outside Armagh College. The incident, in 1994, had a profound effect on the course of her life and the career choices she has made